3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
47.80
+2.75 (6.10%)
At close: Dec 5, 2025
20.86%
Market Cap3.72B
Revenue (ttm)324.87M
Net Income (ttm)133.88M
Shares Out77.84M
EPS (ttm)1.71
PE Ratio27.99
Forward PEn/a
Dividend0.53 (1.18%)
Ex-Dividend DateJul 7, 2025
Volume457,792
Average Volume151,281
Open45.15
Previous Close45.05
Day's Range45.00 - 48.10
52-Week Range37.55 - 73.50
Beta0.29
RSI62.83
Earnings DateNov 13, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.